• 7 Hits
  • Search Condition : Filter (MeSH = Phenylurea Compounds)
Species Resource Title
Human and Animal Cells C2C12(RCB0987) Lenvatinib causes reduced expression of carnitine/organic cation transporter 2 and carnitine deficiency in the skeletal muscle of rats.
Human and Animal Cells HuH-7 Erlotinib and sorafenib in an orthotopic rat model of hepatocellular carcinoma.
Human and Animal Cells Hep G2 , HuH-7 Activation of JNK and high expression level of CD133 predict a poor response to sorafenib in hepatocellular carcinoma.
Human and Animal Cells Combination therapy for hepatocellular carcinoma: additive preclinical efficacy of the HDAC inhibitor panobinostat with sorafenib.
Human and Animal Cells KU812(RCB0495) , K562 Sorafenib induces apoptosis specifically in cells expressing BCR/ABL by inhibiting its kinase activity to activate the intrinsic mitochondrial pathway.
Human and Animal Cells YSCCC(RCB1549) , HuH-28(RCB1943) Potent in vitro and in vivo antitumor activity of sorafenib against human intrahepatic cholangiocarcinoma cells.
Human and Animal Cells A549(RCB0098) Activation of cytosolic phospholipase A2alpha by epidermal growth factor (EGF) and phorbol ester in HeLa cells: different effects of inhibitors for EGF receptor, protein kinase C, Src, and C-Raf.